Scholarlink

Background <p>The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.</p> Main body <p>This selection of highlights provides commentary on 25 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.</p> Conclusion <p>Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月26日

查看全文
  • Oliver C. Kiss,
  • Ivan Penuelas,
  • Ana Rey,
  • Zhi Yang,
  • Nic Gillings,
  • Ambi Pillai,
  • Emiliano Cazzola,
  • Raymond M. Reilly,
  • Carlotta Taddei,
  • Jeff Liu,
  • Michael van Dam,
  • Shozo Furumoto,
  • Junbo Zhang,
  • Emerson Soares Bernardes,
  • Filippo Lodi,
  • Winnie Deuther-Conrad,
  • Ya-Yao Huang,
  • Yohannes Jorge Lagebo,
  • Fany P. Ekoume,
  • Miguel A. Avila-Rodriguez,
  • Beverley Summers,
  • Amal Elrefaei,
  • Maria Salgueiro,
  • Catarina F. Ramogida,
  • Peter J. H. Scott

摘要

Background

The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals.

Main body

This selection of highlights provides commentary on 25 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals.

Conclusion

Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.